Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

Completed · Phase 2

Conditions studied: Macular Telangiectasia Type 2

In brief

This is a multi-center, open-label, 6-month study to evaluate the safety of bilateral CNTF implants in participants with Macular Telangiectasia Type 2.

Key facts

Study ID

NCT04729972

Run by

Neurotech Pharmaceuticals

People needed

33

Starts

2021-07-21

Expected to finish

2022-12-08

Last updated by the study team

2025-03-26

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Jules Stein Eye Institute — Los Angeles, California, United States
• National Eye Institute — Washington D.C., District of Columbia, United States
• Bascom Palmer — Miami, Florida, United States
• Massachusetts Eye and Ear Infirmary, Retina Service — Boston, Massachusetts, United States
• University of Michigan, Kellogg Eye Center — Ann Arbor, Michigan, United States
• Retina Associates of Cleveland, Inc. — Beachwood, Ohio, United States
• Retina Consultants of Texas — Houston, Texas, United States
• Save Sight Institute — Sydney, New South Wales, Australia
• Centre for Eye Research Australia — East Melbourne, Victoria, Australia
• Lions Eye Institute — Nedlands, Western Australia, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.